Endocrine Dysfunction in Primary Mitochondrial Diseases

• by Rachel Varughese, Shamima Rahman

• February 1, 2025

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

• by Kathryn Wighton

• May 27, 2026

• 6 min

From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy

• by Zhiwei Xu, Shi Bai, Caidi He, Xiaobei Lv, Qin Li, Qile Mao, Haijian Wu, Peter Wang

• May 13, 2026